Crinetics Pharmaceuticals...

38.12
-0.09 (-0.24%)
At close: Jan 28, 2025, 3:08 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16
Net Income -214.53M -163.92M -107.64M -73.81M -50.42M -27.11M -9.16M -6.02M
Depreciation & Amortization 1.10M 983.00K 922.00K 948.00K 887.00K 471.00K 128.00K 92.00K
Stock-Based Compensation 40.94M 28.27M 17.35M 10.43M 6.29M 2.32M 271.00K 270.00K
Other Working Capital -6.60M -3.38M -5.20M -2.35M -2.83M -2.06M -768.00K -111.00K
Other Non-Cash Items 26.63M 850.00K -739.00K 261.00K 222.00K -433.00K 480.00K 154.00K
Deferred Income Tax -28.48M n/a 422.00K -227.00K -1.23M n/a n/a n/a
Change in Working Capital 8.04M 18.61M 1.10M 376.00K -2.13M 5.30M -721.00K 189.00K
Operating Cash Flow -166.31M -115.20M -88.59M -62.03M -46.38M -19.46M -9.48M -5.47M
Capital Expenditures -4.69M -1.66M -436.00K -186.00K -492.00K -1.06M -304.00K -190.00K
Acquisitions 195.72M 34.00K 422.00K -227.00K -1.23M n/a n/a n/a
Purchase of Investments -532.86M -329.82M -125.40M -135.59M -108.14M -118.40M n/a n/a
Sales Maturities Of Investments 337.13M 157.49M 69.36M 136.00M 150.29M n/a n/a n/a
Other Investing Acitivies -195.72M -34.00K -422.00K 227.00K 1.23M -118.40M n/a n/a
Investing Cash Flow -200.41M -173.98M -56.48M 217.00K 41.67M -119.46M -304.00K -190.00K
Debt Repayment n/a n/a n/a n/a n/a n/a -212.00K -48.00K
Common Stock Repurchased n/a n/a n/a n/a -59.00K n/a n/a -5.00K
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 19.93M 4.72M 3.14M 288.00K 126.00K 63.73M 12.04M -10.00K
Financial Cash Flow 388.94M 121.96M 252.68M 114.57M 67.00K 170.20M 11.82M -53.00K
Net Cash Flow 22.22M -167.22M 107.61M 52.76M -4.65M 31.28M 2.04M -5.71M
Free Cash Flow -171.00M -116.86M -89.02M -62.21M -46.87M -20.52M -9.78M -5.66M

Create Price Alert on CRNX

Your price alert will notify you when the stock price is above 38.12.

Add to Watchlist